{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:42:28Z","timestamp":1759693348659,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005717","name":"Institute of Evolution at the University of Haifa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.109834","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T22:14:48Z","timestamp":1589580888000},"page":"109834","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Novel harmala-ocudelic tuning (HOT) for ocular disorders"],"prefix":"10.1016","volume":"143","author":[{"given":"E.S.","family":"Lansky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.mehy.2020.109834_b0005","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.tim.2015.08.001","article-title":"Roles of indole as an interspecies and interkingdom signaling molecule","volume":"23","author":"Lee","year":"2015","journal-title":"Trends Microbiol"},{"issue":"Pt 1","key":"10.1016\/j.mehy.2020.109834_b0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N, N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res Bull"},{"issue":"7\u20138","key":"10.1016\/j.mehy.2020.109834_b0015","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/dta.422","article-title":"A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955\u20132010","volume":"4","author":"Barker","year":"2012","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.mehy.2020.109834_b0020","first-page":"1040","article-title":"Serotonin receptor subtype mRNA expression in human ocular tissues, determined by RT-PCR","volume":"12","author":"Sharif","year":"2006","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.mehy.2020.109834_b0025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cell.2017.01.012","article-title":"A receptor on acid","volume":"168","author":"Chen","year":"2017","journal-title":"Cell"},{"issue":"9\u201310","key":"10.1016\/j.mehy.2020.109834_b0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1387\/ijdb.130204mo","article-title":"Nardi I Unraveling new roles for serotonin receptor 2B in development: Key findings from Xenopus","volume":"57","author":"Ori","year":"2013","journal-title":"Int J Dev Biol"},{"issue":"4","key":"10.1016\/j.mehy.2020.109834_b0035","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/dneu.22391","article-title":"Serotonin receptor 2C regulates neurite growth and is necessary for normal retinal processing of visual information","volume":"77","author":"Trakhtenberg","year":"2017","journal-title":"Dev Neurobiol."},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/cxo.12415","article-title":"Influence of selective serotonin reuptake inhibitors on ocular surface","volume":"100","author":"Acan","year":"2017","journal-title":"Clin Exp Optom."},{"issue":"6","key":"10.1016\/j.mehy.2020.109834_b0045","doi-asserted-by":"crossref","first-page":"e692","DOI":"10.4088\/JCP.15m10038","article-title":"Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma","volume":"77","author":"Chen","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.mehy.2020.109834_b0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jad.2017.03.044","article-title":"Antidepressants and risk of cataract development: A population-based, nested case-control study","volume":"215","author":"Chou","year":"2017","journal-title":"J Affect Disord"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2020.109834_b0055","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jop.2017.0124","article-title":"Pharmacology of serotonin receptors causing contraction of isolated bovine posterior ciliary arteries: role in ocular blood flow","volume":"34","author":"Njie-Mbye","year":"2018","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.mehy.2020.109834_b0060","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1167\/iovs.10-6304","article-title":"Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress","volume":"52","author":"Collier","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.mehy.2020.109834_b0065","doi-asserted-by":"crossref","first-page":"8108","DOI":"10.1167\/iovs.10-6418","article-title":"Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist","volume":"52","author":"Collier","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0070","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.1685-18.2018","article-title":"Activation of 5-HT1A receptors promotes retinal ganglion cell function by inhibiting the cAMP-PKA pathway to modulate presynaptic GABA release in chronic glaucoma","volume":"39","author":"Zhou","year":"2019","journal-title":"J Neurosci"},{"issue":"13","key":"10.1016\/j.mehy.2020.109834_b0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fncel.2019.00167","article-title":"5-HT1A receptor agonist promotes retinal ganglion cell function by inhibiting OFF-type presynaptic glutamatergic activity in a chronic glaucoma model","volume":"3","author":"Zhou","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0080","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2174\/138945010791591278","article-title":"Serotonin-2 receptor agonists as novel ocular hypotensive agents and their cellular and molecular mechanisms of action","volume":"11","author":"Sharif","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"6","key":"10.1016\/j.mehy.2020.109834_b0085","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/jop.2006.22.389","article-title":"Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension","volume":"22","author":"Sharif","year":"2006","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.mehy.2020.109834_b0090","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1167\/iovs.06-0062","article-title":"Human trabecular meshwork cells express functional serotonin-2A (5HT2A) receptors: role in IOP reduction","volume":"47","author":"Sharif","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.mehy.2020.109834_b0095","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1242\/jeb.124.1.307","article-title":"Fine tuning of neuronal electrical activity: modulation of several ion channels by intracellular messengers in a single identified nerve cell","volume":"124","author":"Lotshaw","year":"1986","journal-title":"J Exp Biol"},{"issue":"2","key":"10.1016\/j.mehy.2020.109834_b0100","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/jn.2001.85.2.828","article-title":"Serotonin effects on frequency tuning of inferior colliculus neurons","volume":"85","author":"Hurley","year":"2001","journal-title":"J Neurophysiol"},{"issue":"6","key":"10.1016\/j.mehy.2020.109834_b0105","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.neuropharm.2008.06.014","article-title":"Fine-tuning serotonin 2c receptor function in the brain: molecular and functional implications","volume":"55","author":"Berg","year":"2008","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0110","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0024-3205(00)00992-9","article-title":"Modulation of serotonin transporter function by interleukin-4","volume":"68","author":"M\u00f6ssner","year":"2001","journal-title":"Life Sci"},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022482","article-title":"Serotonin-mediated tuning of human helper T cell responsiveness to the chemokine CXCL12","volume":"6","author":"Magrini","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.mehy.2020.109834_b0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.exer.2005.03.021","article-title":"Retinal serotonin, eye growth and myopia development in chick","volume":"81","author":"George","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.mehy.2020.109834_b0125","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/eye.1987.41","article-title":"Presbyopia: An animal model and experimental approaches for the study of the mechanism of accommodation and ocular ageing","volume":"1","author":"Bito","year":"1987","journal-title":"Eye"},{"issue":"7","key":"10.1016\/j.mehy.2020.109834_b0130","first-page":"20","article-title":"Age-related neurochemical changes in the vestibular nuclei","volume":"3","author":"Smith","year":"2016","journal-title":"Front Neurol"},{"key":"10.1016\/j.mehy.2020.109834_b0135","series-title":"The Antipodes of the Mind: Charting the Phenomenology of the Ayahuasca Experience","first-page":"488","author":"Shanon","year":"2003"},{"key":"10.1016\/j.mehy.2020.109834_b0140","series-title":"Harmal: The Genus Peganum","first-page":"241","author":"Lansky","year":"2017"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0145","first-page":"55","article-title":"Effect of liposome-encapsulated total alkaloid of harmaline on rabbit lens epithelial cells: experimental study on the prevention of posterior capsule opacification","volume":"15","author":"Wu","year":"1999","journal-title":"Yan Ke Xue Bao"},{"key":"10.1016\/j.mehy.2020.109834_b0150","series-title":"The Psychedelic Renaissance: Reassessing the Role of Psychedelic Drugs in 21st Century Psychiatry and Society","first-page":"402","author":"Sassa","year":"2017"},{"key":"10.1016\/j.mehy.2020.109834_b0155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2018.11.010","article-title":"Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function","volume":"197","author":"Johnson","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"9","key":"10.1016\/j.mehy.2020.109834_b0160","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrn2884","article-title":"The neurobiology of psychedelic drugs: implications for the treatment of mood disorders","volume":"11","author":"Vollenweider","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2020.109834_b0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuropharm.2018.02.018","article-title":"Psychedelics: Where we are now, why we got here, what we must do","volume":"142","author":"Belouin","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.mehy.2020.109834_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/09540261.2018.1482261","article-title":"Therapeutic use of classic psychedelics to treat cancer-related psychiatric distress","volume":"30","author":"Ross","year":"2018","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"10.1016\/j.mehy.2020.109834_b0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2174\/1570159X16666180125095902","article-title":"Ayahuasca: Psychological and physiologic effects, pharmacology and potential uses in addiction and mental illness","volume":"17","author":"Hamill","year":"2019","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2020.109834_b0180","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/2045125316638008","article-title":"Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): A systematic review of clinical trials published in the last 25 years","volume":"6","author":"Dos Santos","year":"2016","journal-title":"Ther Adv Psychopharmacol."},{"issue":"2","key":"10.1016\/j.mehy.2020.109834_b0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.120128","article-title":"Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin","volume":"38","author":"Young","year":"2013","journal-title":"J Psychiatry Neurosci"},{"issue":"5210","key":"10.1016\/j.mehy.2020.109834_b0190","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/2231061a0","article-title":"Binding of tryptamine and allied compounds to nucleic acids","volume":"223","author":"Smythies","year":"1969","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0195","first-page":"19","article-title":"An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids","volume":"5","author":"Sobhani","year":"2002","journal-title":"J Pharm Pharm Sci."},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0200","first-page":"80","article-title":"Harmine-izing immunity","volume":"16","author":"Fehervari","year":"2016","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.mehy.2020.109834_b0205","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jmt\/9.2.64","article-title":"The use of music in psychedelic (LSD) psychotherapy","volume":"9","author":"Bonny","year":"1972","journal-title":"J Music Ther"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0210","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.1038\/s41598-017-07208-6","article-title":"Suppression of presbyopia progression with pirenoxine eye drops: experiments on rats and non-blinded, randomized clinical trial of efficacy","volume":"7","author":"Tsuneyoshi","year":"2017","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"10.1016\/j.mehy.2020.109834_b0215","first-page":"361","article-title":"Recent advances in the treatment of presbyopia","volume":"69","author":"Van Cauwenberge","year":"2014","journal-title":"Rev Med Liege"},{"issue":"6","key":"10.1016\/j.mehy.2020.109834_b0220","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7150\/ijbs.7.715","article-title":"Protective effects of Morus alba leaves extract on ocular functions of pups from diabetic and hypercholesterolemic mother rats","volume":"7","author":"El-Sayyad","year":"2011","journal-title":"Int J Biol Sci."},{"key":"10.1016\/j.mehy.2020.109834_b0225","series-title":"Ayahuasca: Rituals, Potions, and Visionary Art from Amazonia","first-page":"300","author":"Adelaars","year":"2006"},{"first-page":"200","year":"1973","series-title":"Hallucinogens and Shamanism","key":"10.1016\/j.mehy.2020.109834_b0230"},{"key":"10.1016\/j.mehy.2020.109834_b0235","series-title":"Vine of the Soul: Medicine Men, Their Plants and Rituals in the Colombian Amazon","first-page":"282","author":"Schultes","year":"1992"},{"key":"10.1016\/j.mehy.2020.109834_b0240","series-title":"The Fellowship of the River: A Medical Doctor\u2019s Exploration into Traditional Amazonian Plant Medicine","first-page":"272","author":"Tafur","year":"2017"},{"key":"10.1016\/j.mehy.2020.109834_b0245","unstructured":"Weil AT. Preface. 2017; to Lansky ES, Lansky S, Paavilainen HM. 2017; Harmal: The Genus Peganum. Boca Raton, FL: CRC Press, p. 241."},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0250","first-page":"55","article-title":"Remembering the self: A review of Dr. Joseph Tafur\u2019s The Fellowship of the River","volume":"159","author":"Lansky","year":"2020","journal-title":"Harefuah"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0255","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2752\/175169608783489116","article-title":"Biblical entheogens: A speculative hypothesis","volume":"1","author":"Shanon","year":"2008","journal-title":"Time Mind"},{"issue":"61","key":"10.1016\/j.mehy.2020.109834_b0260","doi-asserted-by":"crossref","first-page":"pe12","DOI":"10.1126\/scisignal.261pe12","article-title":"When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor","volume":"2","author":"Su","year":"2009","journal-title":"Sci Signal."},{"issue":"7","key":"10.1016\/j.mehy.2020.109834_b0265","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.euroneuro.2016.03.012","article-title":"Inhibition of alpha oscillations through serotonin-2A receptor activation underlies the visual effects of ayahuasca in humans","volume":"26","author":"Valle","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.mehy.2020.109834_b0270","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00702-009-0308-8","article-title":"Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter","volume":"116","author":"Cozzi","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1016\/j.mehy.2020.109834_b0275","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fphar.2018.00330","article-title":"Hypothesis: The psychedelic ayahuasca heals traumatic memories via a sigma 1 receptor-mediated epigenetic-mnemonic process","volume":"9","author":"Inserra","year":"2018","journal-title":"Front Pharmacol"},{"issue":"5916","key":"10.1016\/j.mehy.2020.109834_b0280","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N, N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mehy.2020.109834_b0285","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1124\/jpet.102.040584","article-title":"Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites","volume":"303","author":"Campana","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"10.1016\/j.mehy.2020.109834_b0290","doi-asserted-by":"crossref","first-page":"6607","DOI":"10.1007\/s11033-012-1491-5","article-title":"Pregnenolone sulfate decreases intraocular pressure and changes expression of sigma receptor in a model of chronic ocular hypertension","volume":"39","author":"Sun","year":"2012","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3892\/mmr.2017.6647","article-title":"\u03c3-1 receptor stimulation protects against pressure-induced damage through InsR-MAPK signaling in human trabecular meshwork cells","volume":"16","author":"Meng","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.mehy.2020.109834_b0300","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-319-50174-1_20","article-title":"The role of sigma 1 receptor as a neuroprotective target in glaucoma","volume":"964","author":"Mysona","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.mehy.2020.109834_b0305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1371\/journal.pone.0184421","article-title":"receptor regulates ERK activation and promotes survival of optic nerve head astrocytes","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.mehy.2020.109834_b0310","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.yexcr.2006.01.004","article-title":"Silencing of sigma-1 receptor induces cell death in human lens cells","volume":"312","author":"Wang","year":"2006","journal-title":"Exp Cell Res"},{"issue":"11\u201312","key":"10.1016\/j.mehy.2020.109834_b0315","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.mad.2012.09.005","article-title":"Sigma 1 receptor stimulation protects against oxidative damage through suppression of the ER stress responses in the human lens","volume":"133","author":"Wang","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.mehy.2020.109834_b0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/978-3-319-50174-1_19","article-title":"Peeking into sigma-1 receptor functions through the retina","volume":"964","author":"Mavlyutov","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mehy.2020.109834_b0325","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.preteyeres.2018.07.003","article-title":"Sigma 1 receptor: A novel therapeutic target in retinal disease","volume":"67","author":"Smith","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.mehy.2020.109834_b0330","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.exer.2014.10.007","article-title":"Sigma-1 receptor stimulation protects retinal ganglion cells from ischemia-like insult through the activation of extracellular-signal-regulated kinases 1\/2","volume":"128","author":"Mueller","year":"2014","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.mehy.2020.109834_b0335","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1167\/iovs.16-19199","article-title":"Sigma-1 receptor regulates mitochondrial function in glucose- and oxygen-deprived retinal ganglion cells","volume":"58","author":"Ellis","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00441-013-1774-8","article-title":"Sigma receptor 1 modulates ER stress and Bcl2 in murine retina","volume":"356","author":"Ha","year":"2014","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.mehy.2020.109834_b0345","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-319-50174-1_18","article-title":"The Role of sigma1R in mammalian retina","volume":"964","author":"Wang","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/j.mehy.2020.109834_b0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13024-017-0202-z","article-title":"Role of the sigma-1 receptor chaperone in rod and cone photoreceptor degenerations in a mouse model of retinitis pigmentosa","volume":"12","author":"Yang","year":"2017","journal-title":"Mol Neurodegener"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720304801?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720304801?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:22:39Z","timestamp":1759692159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720304801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":70,"alternative-id":["S0306987720304801"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109834","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel harmala-ocudelic tuning (HOT) for ocular disorders","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109834","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109834"}}